PATIENTS

Clinical Research

We Provide a Superior Quality of Care

At Harmonex Neuroscience Research, patients are given the opportunity to try new treatments for their conditions. Some of these treatments are already FDA approved and are currently being used by doctors. However, pharmaceutical companies may find that certain medications are more effective in a different population than intended. When this happens the companies will request that clinical trials be conducted.

Clinical trials (also known as clinical research) are research studies in human volunteers that investigate treatments and observe patient performance with new treatments. They play an important role in developing new treatment options for a variety of diseases.

Before any new treatment can be tested in humans, it must have shown positive results in the laboratory and/or in animal studies. Interventional trials determine whether experimental treatments or new ways of using known therapies are safe and effective under controlled environments. Observational trials address health issues in large groups of people or populations in natural settings.

The United States Food and Drug Administration (FDA) monitors most clinical trials to protect the participants and the general public. Ultimately, the FDA reviews and analyzes data from successful clinical trials to determine whether the experimental treatment should be approved for the treatment of a specific disease or disorder.

Clinical trials may be carried out using completely new treatment options or using treatments that are already available. Clinical trials are the safest and quickest way to confirm whether new treatments are truly beneficial for patients.

These treatment options and the doctor’s visits are free. Harmonex study patients receive the highest level of care available and are monitored and evaluated at greater levels than most patients.

Study patients typically receive full health screenings, extensive lab work and cardiovascular assessments, medications, and doctor’s visits; all at no cost to the patient.

Our research coordinators are fully trained in conducting and administering clinical trials. They have undergone extensive training in good clinical practice and thorough training in Harmonex Research standard operating procedures.

Currently Enrolling Clinical Trials

ADHD Study for Teens

Harmonex is conducting a clinical trial for adolescents with ADHD. Any male or female participants 12 to 17 years of age  with ADHD are eligible to enroll in this study.

Happy children lying in soft cubes, playroom

ADHD Study for Children And Teens

Harmonex is conducting a clinical trial for children with ADHD. Any male or female participants ages 6 to 17 with ADHD are eligible for this study.

ADHD Virtual Study for Children

Harmonex is conducting a clinical trial for children with ADHD. Any female participants 6 to 13 years of age with ADHD are eligible to enroll in this study.

Autism Study for Teens and Adults

Harmonex is conducting a clinical trial for Autism. Any male or female participants ages 13-35 with Autism are eligible for this study.

Siblings playing together

Autism with Irritability Study for Children and Teen's

Harmonex is conducting a clinical trial for children and adolescents with Irritability associated with Autism Disorder. Any male or female participants 5-17 years of age with Irritablity associated with Autistic Disorder are eligible to enroll in this study.

Cheerful siblings playing twister game on floor having fun indoor
CLOSED

Generalized Anxiety Disorder Study for Children and Teen's

Harmonex is conducting a clinical trial for children and adolescents with generalized anxiety disorder. Any male or female participants ages 7 – to 17 years old with generalized anxiety symptoms are eligible for this study.

Young couple having marriage counselling

Major Depression - Investigational Medication or Placebo Plus Antidepressant for Adults

Harmonex is conducting a clinical trial for adults with Major Depression. Any male or female participants ages 19 to 64 with Major Depression are eligible for this study.

CLOSED

Major Depression Study - Adjunctive Therapy for Adults

Harmonex is conducting a clinical trial for adults with Major Depression. Any male or female participants 19 to 65 years of age with Major Depression are eligible to enroll in this study.

Post Traumatic Stress Disorder for Adults

Harmonex is conducting a clinical trial for adults with Post Tramatic Stress Disorder. Any male or female participants ages 19 to 65 with PTSD are eligible to enroll in this study.

Bipolar and Schizophrenia Study for Adolescents

Harmonex is conducting a clinical trial for adolescents with Bipolar and/or Schizophrenia. Any male or female participants 13 to 17 years of age with Bipolar and/or Schizophrenia are eligible to enroll in this study.

Schizophrenia with Adjunctive Treatment for Adolescents

Harmonex is conducting a clinical trial for adolescents with Schizophrenia. Male and female participants ages 12 – 17 are eligible for this study.
Young Girl Talking With Counselor At Home
CLOSED

Tourette's Disorder for Children and Teen's

Harmonex is conducting a clinical trial for children and adolescents with Tourette’s Disorder. Any male or female participants 6 to 17 years of age with Tourette’s Disorder are eligible to enroll in this study.

Give Us A Call

Contact Us

Want to learn more about Harmonex Neuroscience Research?